France Amyloidosis Treatment Market Size & Outlook

The amyloidosis treatment market in France is expected to reach a projected revenue of US$ 447.0 million by 2028. A compound annual growth rate of 8.2% is expected of France amyloidosis treatment market from 2022 to 2028.
Revenue, 2021 (US$M)
$257.8
Forecast, 2028 (US$M)
$447.0
CAGR, 2022 - 2028
8.2%
Report Coverage
France

France amyloidosis treatment market highlights

  • The France amyloidosis treatment market generated a revenue of USD 257.8 million in 2021 and is expected to reach USD 447.0 million by 2028.
  • The France market is expected to grow at a CAGR of 8.2% from 2022 to 2028.
  • In terms of segment, al was the largest revenue generating type in 2021.
  • ATTR is the most lucrative type segment registering the fastest growth during the forecast period.


Amyloidosis treatment market data book summary

Market revenue in 2021USD 257.8 million
Market revenue in 2028USD 447.0 million
Growth rate8.2% (CAGR from 2021 to 2028)
Largest segmentAl
Fastest growing segmentATTR
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationAL, AA, ATTR
Key market players worldwidePfizer Inc, Ionis Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd, Johnson & Johnson, Alnylam Pharmaceuticals Inc


Other key industry trends

  • In terms of revenue, France accounted for 2.6% of the global amyloidosis treatment market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Europe, Germany amyloidosis treatment market is projected to lead the regional market in terms of revenue in 2028.
  • France is the fastest growing regional market in Europe and is projected to reach USD 447.0 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Amyloidosis Treatment Market Scope

Amyloidosis treatment market segmentation & scope
AL
AA
ATTR
Chemotherapy
Immunotherapy
Combination Therapy
Targeted Therapy
Supportive Therapy
Pipeline Therapy

Amyloidosis Treatment Market Companies

Name Profile # Employees HQ Website

France amyloidosis treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to amyloidosis treatment market will help companies and investors design strategic landscapes.


Al was the largest segment with a revenue share of 65.98% in 2021. Horizon Databook has segmented the France amyloidosis treatment market based on al, aa, attr covering the revenue growth of each sub-segment from 2018 to 2028.


Reasons to subscribe to France amyloidosis treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France amyloidosis treatment market databook

  • Our clientele includes a mix of amyloidosis treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France amyloidosis treatment market , including forecasts for subscribers. This country databook contains high-level insights into France amyloidosis treatment market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France amyloidosis treatment market size, by type, 2018-2028 (US$M)

France Amyloidosis Treatment Market Outlook Share, 2021 & 2028 (US$M)

France amyloidosis treatment market size, by type, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more